comprehensive -WSS

comprehensive

author：focus 2025-09-29 09:02:05 - browse：95

The Food and Drug Administration on Tuesday approved brexanolone, the first drug specifically targeted to treat postpartum depression — the most common complication of childbirth. Yet it’s a condition that often goes untreated because new mothers fear being stigmatized if they report symptoms.

Brexanolone is the first drug developed by and approved from Sage Therapeutics. The Cambridge, Mass.-based biotech company will market the new medicine under the brand name Zulresso.

“This approval is important for postpartum depression patients and it’s important for our company. It’s rare in your career when you can introduce a new medicine that is different from what’s out there,” said Sage CEO Jeff Jonas.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

Wikipedia

WSS

Illinois to ban advertising for guns allegedly marketed to kids and militants

Four alarming medical procedures we’re glad history forgot

Republican states more likely to report Covid vaccine side effects

'The Exorcist' director William Friedkin dead at 87

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

hotspot

comprehensive

focus

Apple is now the first public company to be valued at $3 trillion

Judges halt a Biden rule offering student debt relief for those alleging colleges misled them

Activists slam private health insurers over coverage restrictions

Bird flu reported in person exposed to presumably infected cattle

New air purifier tech could be key to improving indoor air quality

Illinois to ban advertising for guns allegedly marketed to kids and militants

Psychedelics group wrestles with new pharma identity

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Drug repurposing or repositioning? The language matters

Multiple sclerosis has subtypes with different best treatments: study

entertainment

Pancreatic cancer is often deadly, but new discoveries are raising hope

Republican states more likely to report Covid vaccine side effects

The UK government moves asylum

NYC plans to house migrants on an island in the East River

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

Oral obesity drug from Viking Therapeutics hits key early target

leisure time

Wikipedia

Wikipedia

focus